PRDM9 and cancer: Overexpression of H3K27me3 caused by activating mutation or overactivity of Enhancer of zeste homolog 2 (EZH2), a histone methyltransferase and a catalytic component of polycomb repressive complex 2, is a frequent event in many types of cancer [37].